{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:54:59Z","timestamp":1792400099921,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:01:42Z","timestamp":1553626902000},"page":"e260-e267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-9607","authenticated-orcid":false,"given":"Shukaib","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2759-7604","authenticated-orcid":false,"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Badley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-7927","authenticated-orcid":false,"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.03.021_bib0001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157016208784324976","article-title":"Mortality and morbidity of HIV-infected patients receiving HAART: a cohort study","volume":"6","author":"Panos","year":"2008","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0002","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0003","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0005","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0006","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States","volume":"170","author":"Simard","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0007","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0008","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1365-2141.2001.02661.x","article-title":"Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome","volume":"112","author":"Sutton","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0009","article-title":"Higher risk myelodysplastic syndromes in patients with well-controlled HIV infection: clinical features, treatment, and outcome","volume":"2016","author":"Williamson","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0010","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107:dju503","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0011","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1089\/aid.2013.0001","article-title":"Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies","volume":"29","author":"Serrano","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0012","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u220632\/\u220632 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0013","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2008-05-157511","article-title":"Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation","volume":"112","author":"Woolfrey","year":"2008","journal-title":"Blood"},{"issue":"15 suppl","key":"10.1016\/j.bbmt.2019.03.021_bib0014","article-title":"Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)\/AIDS Malignancy Consortium (AMC-080) trial","volume":"35","author":"Ambinder","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00126334-200007010-00017","article-title":"Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia","volume":"24","author":"Schlegel","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0016","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0301-472X(01)00793-7","article-title":"Highly active antiretroviral therapy and allogeneic CD34+ peripheral blood progenitor cells transplantation in an HIV\/HCV coinfected patient with acute myeloid leukemia","volume":"30","author":"Sor\u00e0","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0017","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V99.2.698","article-title":"Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0018","first-page":"S344","article-title":"Allogenic stem cell transplantation in a patient with acute myeloid leukaemia and HIV, hepatitis C infections","volume":"33","author":"Shamansky","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.bmt.1705028","article-title":"Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia","volume":"36","author":"Tomonari","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/QAD.0b013e3280b01836","article-title":"Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART","volume":"21","author":"Avettand-Fenoel","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0021","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbmt.2008.01.010","article-title":"Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma","volume":"14","author":"Bryant","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2008.12.348","article-title":"Feasibility of allogeneic peripheral blood stem cell transplantation (allo-SCT) following reduced intensity conditioning (RIC) in HIV+ patients with hematological malignancies","volume":"15","author":"Hamadani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0023","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0024","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years","volume":"163","author":"H\u00fctter","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/bmt.2009.168","article-title":"Allo-SCT for hematological malignancies in the setting of HIV","volume":"45","author":"Polizzotto","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0026","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1097\/QAD.0000000000001240","article-title":"Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies","volume":"30","author":"Mulanovich","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0027","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2017-04-551606","article-title":"How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation","volume":"130","author":"Alvarnas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002461","article-title":"Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: a case study","volume":"14","author":"Cummins","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0029","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0030","series-title":"ASH Annual Meeting. [Abstract]","article-title":"CCR5 \u220632 cord blood and haploidentical grafts: allogeneic stem cell transplant for an HIV+ AML patient. A case report from the Impaact P1107 Observational Study","author":"Hsu","year":"2018"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0031","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2352-3018(15)00083-1","article-title":"CCR5 \u220632 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report","volume":"2","author":"Duarte","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0032","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbmt.2012.08.019","article-title":"Single cord blood combined with HLA-mismatched third-party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders","volume":"19","author":"Kwon","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12981-016-0114-y","article-title":"Stem cell transplantation in strategies for curing HIV\/AIDS","volume":"13","author":"H\u00fctter","year":"2016","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0034","first-page":"109","article-title":"Progress toward curing HIV infection with hematopoietic cell transplantation","volume":"8","author":"Petz","year":"2015","journal-title":"Stem Cells Cloning"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0036","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbmt.2015.12.007","article-title":"Functionally active HIV-specific T cells that target Gag and Nef can be expanded from virus-naive donors and target a range of viral epitopes: implications for a cure strategy after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Patel","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0037","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ymthe.2018.04.009","article-title":"HIV-specific T cells generated from naive T cells suppress HIV in vitro and recognize wide epitope breadths","volume":"26","author":"Patel","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0038","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.1128\/JVI.01062-15","article-title":"HIV-1 reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell vaccine-induced T cell responses","volume":"89","author":"Andr\u00e9s","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2019.03.021_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbmt.2015.08.006","article-title":"Safety and efficacy of combination antiretroviral therapy in human immunodeficiency virus-infected adults undergoing autologous or allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"22","author":"Johnston","year":"2016","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:41:01Z","timestamp":1738010461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119302046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119302046"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.03.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}